EU Review Gets Under Way For Lumasiran And Lonafarnib
Alnylam And Eiger Will Have Their Products Fast-Tracked
The European Medicines Agency produces a monthly list of the marketing authorizations that are under review at the agency. The latest list contains just two new entries.
